Abstract
Breast cancer susceptibility protein 1 (BRCA1) participates in genomic integrity maintenance through DNA repair, cell cycle checkpoint, protein ubiquitination, and transcriptional regulation. The N-terminus of BRCA1 contains a RING domain which forms two Zn2+ binding sites in an interleaved fashion. A number of deleterious BRCA1 missense mutations, which predispose an individual to a subset of hereditary breast and ovarian cancers, have been identified in the RING domain. Disruption of Zn2+ binding sites and protein structure results in the inactivation of BRCA1 tumor suppression function. An unprecedented D67E BRCA1 mutation, identified in Thai familial breast cancer patients, is located in the vicinity of Zn2+ binding site II, and its pathogenic significance remains elusive. The present study revealed that the D67E BRCA1 RING protein assumes a preformed structure in the absence of Zn2+. The Zn2+-bound mutant protein was more folded, resulting in enhanced proteolytic resistance and dimerization. This indicated that the mutation retained Zn2+ binding, and barely perturbed the native global structure of the BRCA1 RING domain. The complex between D67E BRCA1 and BARD1 RING domains exhibited a substantial ubiquitin ligase activity compared with a defective complex containing the C61G BRCA1 mutation. However, the D67E mutation was slightly less stable toward thermal denaturation. This implies that the D67E mutation might be a neutral or mild cancer-risk modifier of other defective mechanisms underlying BRCA1-mutation-related breast cancer.
Similar content being viewed by others
References
Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC (1990) Science 250:1684–1689
Ford D, Easton DF, Peto J (1995) Am J Hum Genet 57:1457–1462
Gudmundsdottir K, Ashworth A (2006) Oncogene 25:5864–5874
Huen MSY, Sy SMH, Chen J (2010) Nat Rev Mol Cell Biol 11:138–148
O’Donovan PJ, Livingston DM (2010) Carcinogenesis 31:961–967
Brzovic PS, Rajagopal P, Hoyt DW, King MC, Klevit RE (2001) Nat Struct Biol 8:833–837
Gamsjaeger R, Liew CK, Loughlin FE, Crossley M, Mackay JP (2007) Trends Biochem Sci 32:63–79
Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A, Xu XL, Yang MCW, Hwang LY, Bowcock AM, Baer R (1996) Nat Genet 14:430–440
Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J, Livingston DM (1997) Cell 90:425–435
Henderson BR (2005) Bioessays 27:884–893
Mok MTS, Henderson BR (2010) Cell Signal 22:47–56
Brodie KM, Henderson BR (2010) Cell Signal 22:291–302
Ruffner H, Joazeiro CAP, Hemmati D, Hunter T, Verma IM (2001) Proc Natl Acad Sci USA 98:5134–5139
Hashizume R, Fukuda M, Maeda I, Nishikawa H, Oyake D, Yabuki Y, Ogata H, Ohta T (2001) J Biol Chem 276:14537–14540
Chen A, Kleiman FE, Manley JL, Ouchi T, Pan Z-Q (2002) J Biol Chem 277:22085–22092
Wu-Baer F, Lagrazon K, Yuan W, Baer R (2003) J Biol Chem 278:34743–34746
Nishikawa H, Ooka S, Sato K, Arima K, Okamoto J, Klevit RE, Fukada M, Ohta T (2004) J Biol Chem 279:3916–3924
Wu-Baer F, Ludwig T, Baer R (2010) Mol Cell Biol 30:2787–2798
Starita LM, Horwitz AA, Keogh MC, Ishioka C, Parvin JD, Chiba N (2005) J Biol Chem 280:24498–24505
Wu W, Nishikawa H, Hayami R, Sato K, Honda A, Aratani S, Nakajima T, Fukuda M, Ohta T (2007) Cancer Res 67:951–958
Horwitz AA, Affar EB, Heine GF, Shi Y, Parvin JD (2007) Proc Natl Acad Sci USA 104:6614–6619
Wu W, Koike A, Takeshita T, Ohta T (2008) Cell Div 3:1
Thakar A, Parvin JD, Zlatanova J (2010) J Biomol Struct Dyn 27:399–406
Foulkes WD (2010) N Engl J Med 362:755–756
Brzovic PS, Meza JE, King MC, Klevit RE (2001) J Biol Chem 276:41399–41406
Brzovic PS, Keeffe JR, Nishikawa H, Miyamoto K, Fox D III, Fukuda M, Ohta T, Klevit RE (2003) Proc Natl Acad Sci USA 100:5646–5651
Lorick KL, Jensen JP, Fang S, Ong AM, Hatakeyama H, Weissman AM (1999) Proc Natl Acad Sci USA 96:11364–11369
Patmasiriwat P, Bhothisuwan K, Sinilnikova OM, Chopin S, Methakijvaroon S, Badzioch M, Padungsutt P, Vattanaviboon P, Vattanasapt V, Szabo CI, Saunders GF, Goldgar D, Lenoir GM (2002) Hum Mutat 20:230–236
Atipairin A, Canyuk B, Ratanaphan A (2010) Chem Biodivers 7:1949–1967
Engel G (1974) Anal Biochem 61:184–191
Arnold K, Bordoli L, Kopp J, Schwede T (2006) Bioinformatics 22:195–201
Provencher SW, Glöckner J (1981) Biochemistry 20:33–37
Greenfield NJ (2006) Nat Protoc 1:2876–2890
Matthews JM, Kowalski K, Liew CK, Sharpe BK, Fox AH, Crossley M, Mackay JP (2000) Eur J Biochem 267:1030–1038
Pjura P, Matthews BW (1993) Protein Sci 2:2226–2232
Xia Y, Pao GM, Chen H-W, Verma IM, Hunter T (2003) J Biol Chem 278:5255–5263
Brzovic PS, Lissounov A, Christensen DE, Hoyt DW, Kelvit RE (2006) Mol Cell 21:873–880
Mallery DL, Vandenberg CJ, Hiom K (2002) EMBO J 21:6755–6762
Morris JR, Pangon L, Boutell C, Katagiri T, Keep NH, Solomon E (2006) Hum Mol Genet 15:599–606
Pongsavee M, Patmasiriwat P, Saunders GF (2009) Int J Mol Sci 10:4187–4197
Eakin CM, Maccoss MJ, Finney GL, Klevit RE (2007) Proc Natl Acad Sci USA 104:5794–5799
Tsuzuki M, Wu W, Nishikawa H, Hayami R, Oyake D, Yabuki Y, Fukuda M, Ohta T (2006) Cancer Lett 233:108–116
Li L, Ryser S, Dizin E, Pils D, Krainer M, Jefford CE, Bertoni F, Zeillinger R, Irminger-Finger I (2007) Cancer Res 67:11876–11885
Dizin E, Irminger-Finger I (2010) Int J Biochem Cell Biol 42:693–700
Jensen DE, Proctor M, Marquis ST, Gardner HP, Ha SI, Chodosh LA, Ishov AM, Tommerup N, Vissing H, Sekido Y, Minna J, Borodovsky A, Schultz DC, Wilkinson KD, Maul GG, Barlev N, Berger SL, Prendergast GC, Rauscher FJ III (1998) Oncogene 16:1097–1112
Orlowski RZ, Dees EC (2003) Breast Cancer Res 5:1–7
Varshavsky A (2008) J Biol Chem 283:34469–34489
Kenny FS, Hui R, Musgrove EA, Gee JMW, Blamey RW, Nicholson RI, Sutherland RL, Robertson JFR (1999) Clin Cancer Res 5:2069–2076
Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A (1999) Endocr Rev 20:501–534
Wang C, Fan S, Li Z, Fu M, Rao M, Ma Y, Lisanti MP, Albanese C, Katzenellenbogen BS, Kushner PJ, Weber B, Rosen EM, Pestell RG (2005) Cancer Res 65:6557–6567
Gudas JM, Nguyen H, Li T, Cowan KH (1995) Cancer Res 55:4561–4565
Kehn K, Berro R, Alhaj A, Bottazzi ME, Yeh W-I, Klase Z, Duyne RV, Fu S, Kashanchi F (2007) Oncogene 26:5060–5069
Wu W, Sato K, Koike A, Nishikawa H, Koizumi H, Venkitaraman AR, Ohta T (2010) Cancer Res 70:6384–6392
Acknowledgments
This work was supported by grants from the Synchrotron Light Research Institute (1-2548/LS01) and the National Research Council of Thailand (PHA530097S). We would like to thank Udo Heinemann for kind assistance and support, and Rolf Misselwitz and Sandro Keller for CD discussions. The Max-Delbrück Center for Molecular Medicine (Berlin, Germany) and the Pharmaceutical Laboratory Service Center, Faculty of Pharmaceutical Sciences, Prince of Songkla University are also acknowledged for research facilities.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Atipairin, A., Canyuk, B. & Ratanaphan, A. Substitution of aspartic acid with glutamic acid at position 67 of the BRCA1 RING domain retains ubiquitin ligase activity and zinc(II) binding with a reduced transition temperature. J Biol Inorg Chem 16, 217–226 (2011). https://doi.org/10.1007/s00775-010-0718-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-010-0718-y